Global Pricing Innovations (GPI) is a reputable leader in delivering price and market access insights to pharmaceutical and biotechnology firms, with a primary aim of increasing patient access to, and thereby maximising the value of products through dynamic pricing and access solutions. Headquartered in London, GPI offers a best-in-class data analytics platform and, coupled with consulting services, brings evidence-based decision analysis to investment decisions. The company’s flagship product, GPI Horizon, stands as the market’s sole value assessment and price prediction platform. Comprising a team of prominent domain specialists, GPI prides itself on providing high-quality, curated, and rapid insights. The company is well-positioned to offer recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception, and payer analytics. GPI’s technology and service offerings are driven by GPI Pulse 2.0™, a data solution that harnesses GPI’s collective expertise to generate rapid insights.

Company Culture

At GPI, our team is deeply committed to our clients’ success. We bring energy, enthusiasm, and expertise to everything we do, ensuring that clients receive the best possible service. People constitute the crux of our business, and at GPI, we focus on fostering a content, healthy, and mutually beneficial relationship with our staff through the recruitment and retention of top talent in the industry.

GPI’s foundation lies within its intelligently integrated price and market access data, but the strength and value is in what we are able to do with it.